Toxoplasma gondii as a possible causative pathogen of type-1 diabetes mellitus: Evidence from case-control and experimental studies

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201803003178234

Enrollment

104

Registered

2018-03-09

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the relation between toxoplasmosis and diabetes

Interventions

group III

group I

GROUP II

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with symptoms of diabetes (thirst, polydipsia, polyuria, weight loss) were diagnosed as having diabetes once fasting plasma glucose level of ¿ 126 mg/dL (¿ 7.0 mmol/L); and/or 2-h value in 75 g oral glucose tolerance test (OGTT) of ¿ 200 mg/dL (¿ 11.1 mmol/L); and/or random plasma glucose level of ¿ 200 mg/dL

Exclusion criteria

Exclusion criteria: Age below 10 years BMI > 30

Design outcomes

Primary

Measure	Time frame
Serum level of anti-Toxoplasma IgG	—

Secondary

Measure	Time frame
serum glucose level	—

Countries

Egypt

Contacts

Public ContactSamar El-Refai

Lecturer of Parasitology, Menoufia Faculty of Medicine

mmdah1976@gmail.com01090229696

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026